Summary of Purpose
The primary objective of this study is to determine the efficacy of a single intravenous infusion of unrelated donor umbilical cord blood (UCB) for improving functional outcomes in patients with ischemic stroke. Eligible subjects will receive an intravenous infusion of UCB or placebo 3-10 days following stroke. Subjects will not receive immunosuppressive or myeloablative medications prior to the infusion....Read More →
The following dates are available for this trial. Trial information last updated on 6 March 2018.
|14 Mar 2017||30 Nov 2016||1 Apr 2019||1 Apr 2020||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All
- Joanne Kurtzberg, MD
- Study Coordinator